Business Acquisition, Pro Forma Information

The following table summarizes our consolidated results of operations for the three and nine-month periods ended September 30, 2018, as well as unaudited pro forma consolidated results of operations as though the acquisition of Cianna Medical and Vascular Insights had occurred on January 1, 2017 (in thousands, except per common share amounts):


	Three Months Ended				Nine Months Ended
	September 30, 2018				September 30, 2018
	As Reported		Pro Forma		As Reported		Pro Forma
Net sales	$	221,659	$	234,751	$	649,504	$	687,203
Net income		16,619		11,335		32,828		16,496
Earnings per common share:
Basic	$	0.31	$	0.21	$	0.64	$	0.32
Diluted	$	0.30	$	0.21	$	0.62	$	0.31

*	The pro forma results for the three and nine-month periods ended September 30, 2019 are not included in the table above because the operating results for the Cianna Medical and Vascular Insights acquisitions were included in our consolidated statements of income for these periods.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed


	Preliminary Allocation		Adjustments⁽¹⁾		Revised Preliminary Allocation
Assets Acquired
Trade receivables	$	94	$	(39)	$	55
Inventories		349		—		349
Property and equipment		409		—		409
Other long-term assets		30		—		30
Intangibles
Developed technology		31,680		280		31,960
Customer lists		83		—		83
Trademarks		250		—		250
Goodwill		16,950		959		17,909
Total assets acquired		49,845		1,200		51,045

Liabilities Assumed
Trade payables		(58)		—		(58)
Accrued expenses		(261)		—		(261)
Other long-term obligations		(1,522)		—		(1,522)
Deferred income tax liabilities		(4,590)		—		(4,590)
Total liabilities assumed		(6,431)		—		(6,431)

Total net assets acquired	$	43,414	$	1,200	$	44,614

(1) Amounts represent adjustments to the preliminary purchase price allocation first presented in our June 30, 2019 Form 10-Q resulting from our ongoing activities, including reassessment of the assets acquired and liabilities assumed, with respect to finalizing our purchase price allocation for this acquisition. The larger adjustments primarily relate to the valuation of contingent consideration and intangible assets acquired.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed



	Preliminary Allocation		Adjustments⁽¹⁾		Revised Preliminary Allocation
Assets Acquired
Trade receivables	$	6,151	$	—	$	6,151
Inventories		5,803		—		5,803
Prepaid expenses and other current assets		315		—		315
Property and equipment		1,047		—		1,047
Other long-term assets		14		—		14
Intangibles
Developed technology		134,510		—		134,510
Customer lists		3,330		—		3,330
Trademarks		7,080		—		7,080
Goodwill		65,885		(4,506)		61,379
Total assets acquired		224,135		(4,506)		219,629

Liabilities Assumed
Trade payables		(1,497)		—		(1,497)
Accrued expenses		(2,384)		—		(2,384)
Other long-term liabilities		(1,527)		—		(1,527)
Deferred income tax liabilities		(30,363)		4,423		(25,940)
Total liabilities assumed		(35,771)		4,423		(31,348)

Total net assets acquired	$	188,364	$	(83)	$	188,281

(1) Amounts represent adjustments to the preliminary purchase price allocation first presented in our December 31, 2018 Form 10-K resulting from our ongoing activities, including reassessment of the assets acquired and liabilities assumed, with respect to finalizing our purchase price allocation for this acquisition.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed


Inventories	$	5,804
Property and equipment		748
Intangibles
Developed technology		74,000
Customer list		4,200
Trademarks		4,900
In-process technology		2,500
Goodwill		9,728

Total net assets acquired	$	101,880